NextTrip Inc (NTRP) Stock Analysis

NextTrip Inc (NTRP) is a publicly traded company in the CONSUMER CYCLICAL sector. It trades at $2.34, carries a market capitalization of $34.06M. This page summarizes the public market data, fundamentals, and frequently asked questions for NTRP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: CONSUMER CYCLICAL - TRAVEL SERVICES

Exchange: NASDAQ

Key Metrics

• Price: $2.34
• Market Cap: $34.06M
• EPS: $-1.82
• 52-Week High: $5.20
• 52-Week Low: $2.04

About NextTrip Inc

Neurotrope, Inc. is a biopharmaceutical company dedicated to pioneering innovative therapies for Alzheimer’s disease and various neurodegenerative disorders. Based in New York, the company utilizes its proprietary product platform to address substantial unmet medical needs within the aging population, highlighting its commitment to advancing neurological treatment options. With a strong focus on research and development, Neurotrope is positioned to redefine therapeutic standards in neurology,...

GNG Research Analysis

GNG Research scores NextTrip Inc (NTRP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NTRP.

Frequently Asked Questions

Does NTRP pay dividends?

NextTrip Inc (NTRP) does not currently pay a regular dividend.

What is NTRP's market cap?

NextTrip Inc (NTRP) has a market capitalization of $34.06M with a current stock price of $2.34.